Transcriptomics Technologies Market, By Technology (Microarrays, PCR, Gene Regulation Technologies, Next Generation Sequencing), By Application (Clinical Diagnostics, Drug Discovery & Research, Bioinformatics, Comparative Transcriptomics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Jul 2020

Code : CMI3989

Pages :150

Formats :

Excel and PDF

Industry : Biotechnology

Transcriptomics Technologies MarketSize and Trends

Statistics:

The global transcriptomics technologies market is estimated to account for US$ 15,569.1 Mn in terms of value by the end of 2027.

Statistics:

North America held dominant position in the global transcriptomics technologies market in 2019, accounting for 39.2% share in terms of value, followed by Europe and Asia Pacific, respectively.

Statistics:

The global transcriptomics technologies market was valued at US$ 4,625.8 Mn in 2019 and is forecast to reach a value of US$ 15,569.1 Mn by 2027 at a CAGR of 16.4% between 2020 and 2027.

Figure 2: Global Transcriptomics Technologies Market Value (US$ Mn), 2016 – 2027

Market Trends/Key Takeaways

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in May 2019, Siemens Healthineers launched its new Atellica CH Enzymatic Hemoglobin A1c Assay to for diagnosing and monitoring diabetes. Major players in the market are also focused on adopting M&A strategies to expand their product portfolio. For instance, in April 2020, Bio-Rad Laboratories, Inc. acquired Celsee, Inc., a developer of instruments and consumables for the isolation, detection, and analysis of single cells.